| Predictive and prognostic implication of bowel resections during primary cytoreductive surgery in advanced epithelial ovarian cancer T Bartl, R Schwameis, A Stift, T Bachleitner-Hofmann, A Reinthaller, ... International Journal of Gynecological Cancer 28 (9), 1664-1671, 2018 | 41 | 2018 |
| Pre-operative hypoalbuminemia is associated with complication rate and overall survival in patients with vulvar cancer undergoing surgery C Bekos, S Polterauer, V Seebacher, T Bartl, E Joura, A Reinthaller, ... Archives of Gynecology and Obstetrics 300, 1015-1022, 2019 | 32 | 2019 |
| The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer T Bartl, C Bekos, M Postl, R Alexander, S Polterauer, A Stefanie, ... Journal of Gynecologic Oncology 32 (1), e1, 2020 | 24 | 2020 |
| Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: a case report V Paspalj, S Polterauer, N Poetsch, A Reinthaller, C Grimm, T Bartl Gynecologic Oncology Reports 37, 100817, 2021 | 19 | 2021 |
| Patient-derived cell line models revealed therapeutic targets and molecular mechanisms underlying disease progression of high grade serous ovarian cancer C Kreuzinger, I von der Decken, A Wolf, M Gamperl, J Koller, J Karacs, ... Cancer letters 459, 1-12, 2019 | 17 | 2019 |
| Obesity in gynecologic oncology H Kölbl, T Bartl Geburtshilfe und Frauenheilkunde 80 (12), 1205-1211, 2020 | 14 | 2020 |
| Pelvic congestion syndrome (PCS) as a pathology of postmenopausal women: a case report with literature review T Bartl, F Wolf, C Dadak BMC Women's Health 21 (1), 181, 2021 | 13 | 2021 |
| The pretreatment Controlling Nutritional Status score in Ovarian Cancer: influence on Prognosis, Surgical Outcome, and postoperative complication rate C Bekos, C Grimm, L Gensthaler, T Bartl, A Reinthaller, R Schwameis, ... Geburtshilfe und Frauenheilkunde 82 (01), 59-67, 2022 | 9 | 2022 |
| Overweight as a favorable clinical biomarker for checkpoint inhibitor therapy response in recurrent gynecologic cancer patients T Bartl, A Onoprienko, G Hofstetter, L Müllauer, N Poetsch, T Fuereder, ... Biomolecules 11 (11), 1700, 2021 | 6 | 2021 |
| Tumor growth rate estimates are independently predictive of therapy response and survival in recurrent high-grade serous ovarian cancer patients T Bartl, J Karacs, C Kreuzinger, S Pfaffinger, J Kendler, C Ciocsirescu, ... Cancers 13 (05), 1076, 2021 | 6 | 2021 |
| Prognostic role of transcription factor ARID1A in patients with endometrial cancer of no specific molecular profile (NSMP) subtype A Onoprienko, G Hofstetter, L Muellauer, T Dorittke, S Polterauer, ... International Journal of Gynecological Cancer 34 (6), 840-846, 2024 | 4 | 2024 |
| Combined chemotherapy and pembrolizumab salvages multi-chemotherapy agent and avelumab resistant choriocarcinoma: a case report M Lehmann, H Hosa, T Bartl, I Tsibulak, S Polterauer, N Pötsch, MJ Seckl, ... Gynecologic Oncology Reports 49, 101259, 2023 | 4 | 2023 |
| The prognostic value of the Fibrinogen-Albumin-Ratio Index (FARI) in patients with advanced vulvar cancer A Onoprienko, G Hofstetter, T Dorittke, C Bekos, C Grimm, M Polterauer, ... Journal of Personalized Medicine 12 (11), 1882, 2022 | 4 | 2022 |
| Current state and perspectives of checkpoint inhibitors in ovarian cancer treatment T Bartl, V Paspalj, S Polterauer, C Grimm memo-Magazine of European Medical Oncology 13 (2), 202-206, 2020 | 4 | 2020 |
| Interactions of EGFR/PTEN/mTOR-pathway activation and estrogen receptor expression in cervical cancer T Bartl, C Grimm, RM Mader, C Zielinski, G Prager, M Unseld, ... Journal of Personalized Medicine 13 (8), 1186, 2023 | 3 | 2023 |
| Homologous recombination deficiency in breast cancer T Bartl, A Farr memo-Magazine of European Medical Oncology 13 (4), 375-379, 2020 | 3 | 2020 |
| Homologous recombination deficiency in epithelial ovarian cancer T Bartl, V Paspalj, C Grimm memo-Magazine of European Medical Oncology 13, 367-370, 2020 | 3 | 2020 |
| Novel Targeted Agents in Advanced and Recurrent Low-Grade Serous Ovarian Cancer: A Silver Lining in the Therapy of a Chemoresistant Disease? A Onoprienko, T Bartl, C Grimm, N Concin, S Polterauer Cancers 16 (19), 3268, 2024 | 2 | 2024 |
| Successful one-stage resection of intracardiac intravenous leiomyomatosis: A case report M Postl, T Bartl, N Poetsch, A Reinthaller, M Andreas, C Neumayer, ... Gynecologic Oncology Reports 48, 101243, 2023 | 2 | 2023 |
| 816P Laparoscopic versus open-surgery in FIGO stage II endometrioid endometrium cancers: Is there a prognostic effect? AG Zeimet, TP Bargujar, K Leitner, K Steger, T Bartl, C Marth, D Reimer Annals of Oncology 34, S540, 2023 | 1 | 2023 |
